Latest Quarter
Q2 FY2024ended 2024-06-30 · filed 2024-11-01
$156
$-13.36K
$-13.36K
$0.00
N/A
N/A
N/A
N/A
What this quarter tells us
For Q2 FY2024 (ended June 30, 2024), NIKA PHARMACEUTICALS, INC reported revenue of $156 and a net loss of $13,359. Operating loss was also $13,359, with diluted EPS of $0.00. The net loss increased approximately 3.2% year-over-year.
- •Revenue was $156 for Q2 FY2024.
- •Net loss of $13,359, up 3.2% from prior year.
- •Operating loss matched net loss at $13,359.
- •Diluted EPS was $0.00.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.